Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA panel sets review date for Medtronic's Bryan cervical disc implant:

This article was originally published in Clinica

Executive Summary

A US FDA advisory panel is to meet on July 17 2007 to review a second artificial cervical disc made by Medtronic, the company has reported. It will vote on whether or not to recommend that the agency approves the total disc replacement (TDR) system, called Bryan. The company's first cervical TDR product, Prestige, came before the FDA's orthopaedic and rehabilitation devices advisory panel last year, and was given a positive recommendation for approval; the FDA is expected to deliver a final verdict on the device this summer, Medtronic said. The FDA has yet to approve a cervical TDR, although lumber TDRs are already available in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel